Trial Profile
A Double-Blind, Randomized, Multiple-Ascending Dose (MAD) Study to Assess the Pharmacokinetics, Safety and Tolerability of Tylerdipine Hydrochloride (KBP-5660) in Healthy Chinese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs Tylerdipine (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2018 New trial record
- 27 Oct 2018 Results of this and other study (CTR20140862), published in the Clinical Drug Investigation Journal.